- Germany is ready to authorize the delivery of Eurofighter (BAE Systems, Airbus, Leonardo) to Saudi Arabia, according to Reuters.
- The US Department of Justice is about to file an antitrust complaint against Apple.
- Harris calls for the break-up of Bayer, in which he holds a 4% stake.
- Pandora exceeds its sales and earnings forecasts thanks to a solid fourth quarter.
- Synopsys is in advanced talks to acquire Ansys for $35 billion, according to the WSJ.
- Southwestern Energy and Chesapeake Energy are close to a merger, according to the WSJ.
- CMC Markets raises its operating profit forecast.
- Merck in talks to buy Harpoon Therapeutics for around $700 million, according to Bloomberg.
- Honda plans $14 billion project to produce electric vehicles in Canada, according to Nikkei.
- Novartis partners with Isomorphic Labs (Alphabet) for AI-driven drug discovery.
- Berkshire Hathaway settles valuation dispute with Pilot.
- Some of BP Plc's major shareholders have asked the company to approach BAE Systems managing director Charles Woodburn to become the next CEO, according to Sky News.
- The vice-president of China Evergrande Group's EV unit, China Evergrande New Energy, was arrested in China.
- Vinfast plans to invest $2 billion in India. Vinfast appointed its founder and main backer, Pham Nhat Vuong, as CEO on Saturday, as the company plans overseas expansion and increased sales through dealerships.
- Danube wants to buy the last DSM shares at EUR 96 each.
- SoftwareOne confirms talks with Bain.
- Capital A sells its aeronautical activities to AirAsia X.
- Swisscom to cease web hosting business.
- EQT to build and operate data centers for large-scale customers.
- Alcon and Lifecore Biomedical extend contract manufacturing agreement.
- Boeing fell by 8.3% before the opening after Friday's incident involving one of its 737 MAX 9 models.
- Apple - iPhone sales in China fell 30% in the first week of 2024, write Jefferies analysts in a note.
- BlackRock will reduce its global workforce by around 3%, according to Fox Business.
- Nvidia plans to start production of its artificial intelligence chip for the Chinese market in the second quarter of 2024, two sources familiar with the matter said on Monday.
- Boston Scientific announced Monday that it had acquired Axonics for $3.7 billion.
- Moderna on Monday reported preliminary 2023 sales of $6.7 billion for its COVID-19 vaccine, above the lower end of its full-year guidance.
- Regeneron Pharmaceuticals said Monday that its ophthalmic treatment Eylea had recorded preliminary U.S. fourth-quarter sales of $1.34 billion.
- Allison Transmission - The United Auto Workers (UAW) union reached agreement with the auto parts manufacturer on a tentative deal covering 1,500 workers in Indianapolis, the labor organization said Friday.
- Harpoon Therapeutics doubles its share price to $21.10 before the open, as Merck is in advanced talks to buy the group for around $700 million, or $23 per share, Bloomberg News reports.
- Ligand Pharmaceuticals rises 5.2% ahead of opening after its topical treatment for viral skin infection receives FDA approval.
- Cellectar Biosciences said Monday that its treatment for a type of blood cancer had met its primary endpoint in a clinical trial.
- Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the US on Friday.
Global markets live: Merck, Honda, Novartis, Boeing, Nvidia...
Every day, the MarketScreener team selects the most important news about listed companies. Here's a short recap for your convenience: